Herbs (Global Traditional) · European
Comfrey (Symphytum officinale) (Symphytum officinale)
Moderate Evidencebotanical3 PubMed Studies
Hermetica Superfood Encyclopedia
Comfrey (Symphytum officinale) contains allantoin, a purine derivative that accelerates cell proliferation and tissue regeneration. This European herb demonstrates significant anti-inflammatory and analgesic properties through cyclooxygenase inhibition and enhanced collagen synthesis.
Comfrey (Symphytum officinale) is a perennial herb native to Europe that grows in damp grasslands and is cultivated worldwide. Therapeutic preparations are made from roots or leaves, typically extracted using 60% ethanol for topical ointments, with the root extract being the primary clinical form studied.
Multiple randomized controlled trials support topical comfrey root extract for musculoskeletal conditions, including a double-blind, placebo-controlled RCT (n=220) showing significant pain and function improvements in knee osteoarthritis. Comparative trials demonstrated superiority to diclofenac for ankle sprains, though specific PMIDs were not provided in the research dossier.
Clinically studied dose: 10% comfrey root extract ointment (from 60% ethanolic extract) applied topically 3 times daily for 1-3 weeks. For external use only - internal consumption is prohibited due to hepatotoxic pyrrolizidine alkaloids. Consult a healthcare provider before starting any new supplement.
Comfrey leaf and root contain a complex array of bioactive compounds rather than serving as a conventional nutritional source. **Key bioactive compounds:** Allantoin (0.6–4.7% in root, 0.3–0.5% in leaf) is the primary wound-healing agent, promoting cell proliferation and tissue regeneration. Rosmarinic acid (up to 0.2% in leaf extracts) provides anti-inflammatory and antioxidant activity. Mucilage polysaccharides (up to 29% in root) contribute demulcent and soothing properties. **Pyrrolizidine alkaloids (PAs):** Symphytine, lycopsamine, intermedine, and echimidine are present at approximately 0.02–0.18% in root and lower levels in leaf (~0.003–0.02%); these are hepatotoxic and restrict internal use. **Tannins:** Condensed and hydrolyzable tannins (3–8%) contribute astringent and antimicrobial effects. **Phenolic acids:** Caffeic acid, chlorogenic acid, and lithospermic acid contribute to antioxidant capacity. **Triterpene saponins:** Including isobauerenol and β-sitosterol (trace to 0.5%) support anti-inflammatory activity. **Amino acids & protein:** Leaves contain approximately 15–20% crude protein (dry weight basis), including asparagine. **Minerals:** Notable levels of potassium (~2.5–3.5% dry weight), calcium (~1.0–1.5%), phosphorus (~0.3–0.6%), iron (~100–300 ppm), manganese, and zinc. **Vitamins:** Modest amounts of vitamin C (~30–60 mg/100 g fresh leaf), provitamin A (β-carotene), and B-vitamins (B1, B2, B12 — comfrey is one of the few land plants reported to contain trace vitamin B12, though bioavailability is debated and amounts are nutritionally insignificant at ~0.3–0.5 µg/100 g dry weight). **Fiber:** Leaves contain ~10–15% crude fiber (dry weight). **Fatty acids:** Gamma-linolenic acid (GLA) detected in trace amounts in seed oil. **Bioavailability notes:** Allantoin is readily absorbed topically and is the basis for comfrey's external therapeutic use; rosmarinic acid has moderate oral bioavailability but is primarily utilized in topical formulations for comfrey due to PA toxicity concerns. Topical preparations are standardized to contain allantoin (typically ≥0.4%) and are processed to reduce PA content to below detectable limits (<0.35 µg/g or PA-free) for safe clinical use. Internal consumption is contraindicated due to cumulative PA hepatotoxicity and veno-occlusive disease risk.
Comfrey's primary bioactive compound allantoin promotes cell proliferation by enhancing DNA synthesis and collagen formation. Rosmarinic acid and caffeic acid derivatives inhibit cyclooxygenase-2 (COX-2) and lipoxygenase pathways, reducing prostaglandin E2 and leukotriene synthesis. The herb also contains mucilage polysaccharides that provide protective coating effects on damaged tissues.
A randomized controlled trial (n=220) demonstrated comfrey cream reduced osteoarthritis pain by 54.7% and improved joint function by 58% versus placebo. In acute ankle sprains, comfrey showed superior pain reduction compared to diclofenac (83.2% vs 72.4%). Multiple randomized trials support its efficacy for back pain and wound healing, though most studies used topical preparations. Evidence quality is moderate with consistent positive outcomes across musculoskeletal conditions.
Oral comfrey contains pyrrolizidine alkaloids that can cause hepatotoxicity and should be avoided internally. Topical preparations using alkaloid-free extracts are generally safe but may cause contact dermatitis in sensitive individuals. Comfrey should not be used during pregnancy or breastfeeding due to potential teratogenic effects. No significant drug interactions reported with topical use, but avoid on broken skin due to systemic absorption risk.
